Appendix A: project funding


TABLE OF SPENDING FOR GULF WAR VETERANS’ ILLNESSES RESEARCH
Research Working Group
Persian Gulf Veterans Coordinating Board
March 1, 1999


NOTE: These notes and the attached table replace and supersede Appendix A-2 of the Annual Report to Congress: Federally Sponsored Research on Gulf War Veterans’ Illnesses for 1997 issued March, 1998.

General

All entries for research funding reflect money centrally committed to researchers (both intramural and extramural) to carry out the specific projects. These funds do not cover operational costs for administration, infrastructure, etc. Each department allocates these costs in slightly different ways making it difficult to accurately account for these funds. For example, in VA the research appropriation does not pay for clinician/investigator salaries. By law those funds must come from the patient care appropriation.

A "blank" funding entry generally reflects years in which a project was not active (e.g. it had not started or it had come to an end.

Some multiyear projects receive all of their funding in the fiscal year of the authorization and appropriation. For those, the dollars authorized and appropriated are shown for that fiscal year. The remaining funding entries show $0 for the years that the project is active.

Some intramural projects/programs are supported out of operational costs. For those projects $0 is entered for the funds in the fiscal years that the project is active.

Programs consisting of multiple projects are represented in one of two ways depending on how funds are centrally allocated:

Funds centrally allocated to the program: These programs are shown in the table as a main program indicated by a project designation such as DoD-1, and projects in the program as DoD-1A, DoD-1B, etc. All funds are shown under the main program. Blank funding entries are shown for the individual projects.

Funds centrally allocated to projects within a program: These programs are only indicated by their projects without a main program identifier. For example, VA-2A and VA-2B.

Entries indicated by a "00" (e.g. DoD-00) are initiatives or activities for which funds have been set aside. Generally, these may involve projects that are under peer review; projects approved but under negotiation; or set asides allocated for a new initiatives. In FY’99, $19 M has been set aside for the new DoD Program Element Initiative for Gulf War veteran’s illnesses research.

Funds listed under FY’99 are only projections at this time.

 

Specific

DoD-4 is part of a larger US Army study (DoD-23) conducted at Walter Reed Army Institute of Research. All funding is combined into project DoD-23. DoD-8A and 8B are also parts of a larger US Army study and all funding is combined and shown under program DoD-8.

Funds for DoD-8A, 8B, and 12 have been combined under DoD-12.

In the Report to Congress for 1997, funds for DoD-7B were broken out by level of effort in each fiscal year instead of representing the fiscal year in which funds were committed to this effort. This has been corrected in the current table.

In the Report to Congress for 1997 the table did not show that an additional $127,000 was expended on DoD-16 in FY’97. This has been corrected in the present report.

The table in the Report to Congress for 1997 indicated a projected $2 million to be spent on DoD-18 in FY’98. The actual figure was $290,000. This has been corrected in the current table.

The funding for DoD-66 has been updated in the present table to accurately reflect the fiscal year appropriations from which funds were expended.

HHS-3 was funded from the FY’91 appropriation, which is not included in this accounting.

HHS-4 was funded from the FY’93 appropriation, which is not included in this accounting.

Funds for VA-1 for FY’94 through FY’97 represent an aggregate of funds for both the VA Mortality Study and the VA National Survey of Persian Gulf Veterans. Beginning in FY’98 VA-1 reflects continuation of the VA Mortality Study. Beginning in FY’98 VA–2A, 2B, and 2C reflect funding for separate components of the VA National Survey of Persian Gulf Veterans.

A category has been created for projects and programs jointly funded by VA and DoD. The portion of a project funded by DoD ends in a "D" and the portion of a project funded by VA ends in a "V".

Department of Defense Funding
Department of Health and Human Services Funding
Department of Veterans Affairs Funding
VA/DoD Programs Funding

Research on Gulf War Veterans' Illnesses

Department of Defense Funding

Project #

Title

Status

FY'94

FY'95

FY'96

FY'97

FY'98

94-98 Total

Projected FY'99

DoD-00

1999 DoD Program Element Initiative

Pending

         

$0

$19,000,000

DoD-1

Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors

Ongoing

$725,000

$1,010,000

$2,250,000

$2,000,000

$2,654,000

$8,639,000

$1,500,000

DoD-1A

A Study of Symptoms Among 1500 Seabees

Complete

         

$0

 

DoD-1B

A Comparative Study of Hospitalizations among Active Duty Personnel who Participated in the Gulf War and Similar Personnel who did not

Complete

         

$0

 

DoD-1C

A comparative study of pregnancy outcomes among gulf war veterans and other active-duty personnel

Complete

         

$0

 

DoD-1D

Adverse Reproductive Outcomes in Gulf War veterans

Ongoing

         

$0

 

DoD-1E

Seabee Health Study

Ongoing

         

$0

 

DoD-1F

A Comparison of Nonfederal Hospitalization Experience Among Veterans in California who have separated from active service

Complete

         

$0

 

DoD-1G

Prevalence of Congenital Anomalies Among Children of Persian Gulf War Veterans.

Ongoing

         

$0

 

DoD-2

Physiological and Neurobehavioral Effects in Rodents from Exposure to Pyridostigmine, Fuels, and DEET (short title: Toxicity of Simulated PGW Exposure)

Complete

$90,000

$0

$0

$0

 

$90,000

 

DoD-4

The General Well-Being of Gulf War Era Service Personnel from the States of Pennsylvania and Hawaii: A Survey

Complete

$0

       

$0

 

DoD-7A

Health Risk Assessment of Embedded Depleted Uranium: Behavior, Physiology, Histology, and Biokinetic Modeling

Complete

$897,000

$0

$0

$0

$0

$897,000

 

DoD-7B

Carcinogenicity of Depleted Uranium Fragments

Ongoing

$897,814

$0

$0

$0

$0

$897,814

$0

DoD-8

Research on Diagnostic Tools for Leishmaniasis

Ongoing

$773,000

$895,000

$652,000

$695,000

$694,000

$3,709,000

$0

DoD-8A

Serologic Diagnosis of Viscerotropic Leishmaniasis (VTL)

Complete

         

$0

 

DoD-8B

Development of a Leishmania Skin Test Antigen (LSTA)

Ongoing

         

$0

 

DoD-9

Identification of the Genetic Factors Which Control Tropism in Leishmania

Complete

$0

$150,000

$0

$0

$0

$150,000

 

DoD-10

Pyridostigmine Synergistic Toxicity

Complete

$42,000

$44,000

     

$86,000

 

DoD-11

Male/Female Differential Tolerances to Pyridostigmine Bromide

Complete

$549,000

$359,000

$0

$0

 

$908,000

 

DoD-12

Forward Deployable Diagnostics for Infectious Diseases

Ongoing

$520,000

$1,162,000

$439,000

$932,000

$803,000

$3,856,000

$0

DoD-13

Effects of Persian Gulf War Service on Military Working Dogs

Ongoing

$0

$0

$97,000

$200,000

$120,000

$417,000

$200,000

DoD-14

Risk Factors Among US Army Soldiers for Enrolling on the Department of Veterans Affairs Gulf War

Complete

$120,000

$0

$0

$0

 

$120,000

 

DoD-15

Comparative Mortality Among US Military Personnel Worldwide During Operations Desert Shield and Desert Storm

Complete

$20,000

$0

     

$20,000

 

DoD-16

Kuwait Oil Fire Health Risk Assessment

Complete

$345,000

$137,000

$50,000

$127,000

 

$659,000

 

DoD-17

Retrospective Studies Involving Military Use of Pyridostigmine as a Pretreatment for Nerve Agent Poisoning

Complete

$21,000

       

$21,000

 

DoD-18

Kuwait Oil Fires Troop Exposure Assessment Model (TEAM)

Ongoing

$68,000

$151,000

$770,000

$193,000

$290,000

$1,472,000

$295,000

DoD-19

Persian Gulf Veterans Health Tracking System

Ongoing

 

$25,000

$0

$0

$450,000

$475,000

$450,000

DoD-20

A Statistical Study Correlating Illnesses in Gulf War Veterans to Battlefield Locations of Afflicted US Army Personnel During the Iraq-Kuwait War; Part 1: Method to Relate Troop Deployment and Illnesses in GWVs

Complete

$50,000

$0

     

$50,000

 

DoD-21

Study of Variability In Pyridostigmine Inhibition of Blood Cholinesterases in Healthy Adults and Individuals With Symptoms Following Participation in Operation Desert Storm

Complete

$38,000

$100,000

$0

$0

 

$138,000

 

DoD-22

Chronic Organophosphorus Exposure and Cognition

Complete

$375,000

$0

$0

$0

$0

$375,000

 

DoD-23

Acute and Long-Term Impact of Deployment to Southwest Asia on the Physical and Mental Health of Soldiers and their Families

Complete

$621,000

$688,000

$764,000

$985,000

 

$3,058,000

 

DoD-30

Epidemiological Studies Persian Gulf War Illnesses, PG Women's Health Linkage Study

Ongoing

 

$779,000

$0

$0

$0

$779,000

$0

DoD-31

Dysregulation of the Stress Response in the Persian Gulf Syndrome

Ongoing

 

$971,000

$0

$0

$0

$971,000

$0

DoD-32

Neuropsychological Functioning in Persian Gulf Era Veterans

Ongoing

 

$353,000

$0

$0

$0

$353,000

$0

DoD-33

Effects of Pyridostigmine in Flinders Line Rats Differing in Cholinergic

Ongoing

 

$354,000

$0

$0

$0

$354,000

$0

DoD-34

Characterization of Emissions from Heaters Burning Leaded Diesel Fuel in Unvented Tents

Ongoing

 

$283,000

$0

$0

$0

$283,000

$0

DoD-35

Feasibility of Investigating Whether There is a Relationship Between Birth Defects and Service in the Gulf War

Ongoing

 

$427,000

$10,000

$63,000

$0

$500,000

$0

DoD-36

Fatigue in Persian Gulf Syndrome-Physiologic Mechanisms

Ongoing

 

$416,000

$138,000

$0

$0

$554,000

$0

DoD-37

Neurobehavioral and Immunological Toxicity of Pyridostigmine, Permethrin, and DEET in Male and Female Rats

Ongoing

 

$934,000

$5,000

$0

$0

$939,000

$0

DoD-38

Diagnostic Antigens of Leishmania tropica

Complete

 

$612,000

$0

$0

$0

$612,000

 

DoD-39

A Controlled Epidemiological and Clinical Study into the Effect of Gulf War Service on Servicemen and Women of the United Kingdom Armed

Ongoing

 

$865,000

$0

$28,400

$155,000

$1,048,400

$0

DoD-40

Psychological and Neurobiological Consequences of the Gulf War Experience

Ongoing

 

$264,000

$0

$0

$0

$264,000

$0

DoD-41

Evaluation of Muscle Function in Persian Gulf veterans

Ongoing

 

$906,000

$0

$0

$0

$906,000

$0

DoD-42

The Symptomatic Persian Gulf Veterans Protocol: An Analysis of Risk Factors with an Immunologic and Neuropsychiatric Assessment

Ongoing

   

$700,000

$0

$0

$700,000

$0

DoD-44

Investigation of Seminal Plasma Hypersensitivity Reactions

Ongoing

   

$634,000

$0

$0

$634,000

$0

DoD-45

Physical and Emotional Health of Gulf War Veterans Women

Ongoing

   

$100,000

$100,000

$0

$200,000

$0

DoD-46

Exploratory Data Analysis with the CCEP

Complete

   

$60,000

$100,000

 

$160,000

 

DoD-47

Study of Mycoplasmal Infections in Gulf War Veterans

Complete

   

$112,000

$0

$0

$112,000

 

DoD-48

Assessment of Genomic Instability via Chromosome 7 Inversion Frequency in a Symptomatic Cohort of Gulf War Veterans vs Selected Control Groups

Complete

   

$74,000

$0

 

$74,000

 

DoD-49

Diagnosis and Dosemitry of Exposure to Sulfur Mustard: Development of Standard Operating Procedures and Exploratory Research on Protein Adducts

Ongoing

   

$927,000

$0

$0

$927,000

$0

DoD-50

Toxicokinetics of 0-Ethyl S-(2-Diisopropylaminoethyl) Methylphosphonothioate [(+)-VX] in Rats, Hairless Guinea Pigs and Marmosets - Identification of Metabolic Pathways

Ongoing

   

$699,000

$0

$0

$699,000

$0

DoD-51

Transgenic Engineering of Cholinesterases: Tools for Exploring Cholinergic Responses

Ongoing

$864,000

$0

$0

$864,000

$0

DoD-52

Female Gender and Other Potential Predictors of Functional Health Status Among Persian Gulf War veterans

Ongoing

$414,000

$0

$0

$0

$0

$414,000

$0

DoD-53

Long-Term Effects of Subclinical Exposures to Sarin

Ongoing

   

$1,000,000

$400,000

$0

$1,400,000

$0

DoD-54

Assessment of Subchronic Neurobehavioral and Neuropathologic Effects in Rats

Ongoing

   

$315,000

$100,000

$0

$415,000

$0

DoD-55

Low-Level Exposure to GB Vapor in Air: Diagnosis/Dosimetry, Lowest Observable Effect Levels, Performance-Incapacitation, and Possible

Ongoing

   

$500,000

$136,000

$0

$636,000

$0

DoD-56

Low-Level Sarin Neurotoxicity and Its Modulation by Pyridostigmine

Ongoing

   

$685,000

$100,000

$0

$785,000

$0

DoD-57

Physiologic Effects of Stress in Gulf War Veterans

Ongoing

     

$909,000

$0

$909,000

$0

DoD-58

Illness Among Persian Gulf War Veterans: Case Validation Studies

Ongoing

     

$2,208,000

$0

$2,208,000

$0

DoD-59

Pyridostigmine-induced Neurodegeneration: Role of neuronal Apoptosis

Ongoing

     

$625,000

$0

$625,000

$0

DoD-60

Butyrylcholinesterase Genetic Variants in Persons with Gulf War Illness

Ongoing

     

$125,000

$0

$125,000

$0

DoD-61

Neurophysiologic and Neuropathologic Effects in Monkeys of Low Level Exposures to Sarin, Pyridostigmine, Pesticides, and Botulinum Toxoid

Ongoing

     

$1,586,000

$0

$1,586,000

$0

DoD-62

Sarin and Pyridostigmine Interaction under Physical Stress: Neurotoxic Effects in

Ongoing

     

$201,000

$0

$201,000

$0

DoD-63

PGW Veterans: Epidemiological and Clinical Evidence for Residual Organophosphate Neurotoxicity

Ongoing

     

$1,626,000

$0

$1,626,000

$0

DoD-64

Individual Differences in Neurobehavioral Effects of Pyridostigmine

Ongoing

     

$1,900,000

$18,516

$1,918,516

$0

DoD-65

Multi-Disciplinary Pathophysiologic Studies of Neurotoxic Gulf War-Related Neurologic Syndromes

Pending

     

$3,000,000

$0

$3,000,000

$0

DoD-66

Testing for Mycoplasma Infection: Criterion Validity and Replicability of Nucleoprotein Gene Tracking and Forensic Polymerase Chain Reaction Tests

Ongoing

   

$49,940

$100,000

$63,825

$213,765

$100,000

DoD-67

Antibacterial Treatment Method Based Upon the Excretion of Dead and Decaying Spherical Bacteria

Ongoing

   

$0

$3,400,000

$0

$3,400,000

$0

DoD-69

Five Year Follow-Up of Army Personnel Potentially Exposed to Chemical Warfare

Ongoing

     

$946,160

$0

$946,160

$0

DoD-70

War Syndromes from 1900 to the Present: Symptom Patterns and Long Term Health Outcomes

Ongoing

     

$734,687

$0

$734,687

$115,000

DoD-71

A Comparison of Post-Deployment Hospitalization Incidence between Vietnam and Gulf War Veterans

Ongoing

$0

$0

$0

$566,000

$0

$566,000

$0

DoD-72

Long-Term Effects of Subchronic Exposure to Sarin, Alone and with Stress and Other Chemicals

Ongoing

     

$996,000

$0

$996,000

 

DoD-73

Post-Deployment Morbid Stress, Behavior and Health: Developing a Model for Predicting Morbidity, Mortality, and other Adverse Outcomes

Ongoing

     

$500,000

$0

$500,000

$0

DoD-74

Relationship of Stress Exposures to Health in GWVs

Ongoing

     

$161,489

$1,991,330

$2,152,819

$0

DoD-75

Toxic Interactions of Prophylactic Drugs and Pesticides

Ongoing

       

$1,380,157

$1,380,157

$0

DoD-76

Evaluation of Immunotoxicity Due to Concurrent Exposure to DEET, Pyridostigmine, and JP-8 Jet Fuel

Ongoing

       

$448,369

$448,369

$0

DoD-77

Percutaneous Absorption of Chemical Mixtures Relevant to the Gulf War

Ongoing

       

$760,031

$760,031

$0

DoD-78

Experimental Models of Gulf War Syndrome

Ongoing

       

$2,179,097

$2,179,097

$0

DoD-79

Military Operational Stress-Related Illnesses: Time-course of Stress-Induced Impairment of the

Ongoing

     

$100,200

$0

$100,200

$0

DoD-80

Molecular Regulation of Corticosteroid Receptor Expression in Stress-Responsive Cells

Ongoing

     

$297,400

$0

$297,400

$0

DoD-81

Immunotoxicity Due to Coexposure of DEET, PB, and Stress

Ongoing

     

$300,000

$0

$300,000

$0

DoD-82

Feasibility of Developing a Registry of PTSD-Affected Sibling

Ongoing

     

$172,000

$0

$172,000

 

DoD-83

Risk for Stress-Related Substance Abuse: Effects of Family History of Alcoholism

Ongoing

     

$299,700

$0

$299,700

$0

DoD-84

Psychobiological Alterations Of Persian Gulf War Veterans with and without PTSD

Ongoing

     

$300,000

$0

$300,000

$0

DoD-85

Central Nervous System Cytokines and CRH in Gulf War Veterans with Multiple Unexplained Symptoms

Ongoing

     

$149,900

$149,200

$299,100

$0

DoD-86

Effects of Combat Stress on the Structure and Function of the Hippocampus

Ongoing

     

$300,000

$297,800

$597,800

$0

DoD-87

Measurement and Validation of Psychosocial Risk and Resilience Factors

Ongoing

     

$289,100

$0

$289,100

$0

DoD-88

Clinical Relevance of Novel Immunological Markers in PTSD

Ongoing

     

$242,300

$0

$242,300

$0

DoD-89

Limbic Blood Flow and Opiate Receptor and MR Imaging in PTSD

Ongoing

     

$288,500

$0

$288,500

$0

DoD-90

SPECT Benzodiazepine Receptor and MR Imaging in PTSD

Ongoing

     

$200,000

$100,000

$300,000

$0

DoD-91

Neurological and Circadian Substrates of PTSD-Like Behaviors

Ongoing

     

$300,000

$299,000

$599,000

$0

DoD-92

Traumatic Experiences Enhance Cue-Dependent Learning

Ongoing

     

$249,700

$0

$249,700

$0

DoD-93

Follow-Up Investigation of Troops Exposed to Nerve Agents at Aberdeen Proving

Pending

         

$0

$933,000

  DoD Total Funds  

$6,565,814

$11,885,000

$11,894,940

$29,232,536

$12,853,325

$72,853,325

$22,593,000

 

Department of Health and Human Services Funding

Project #

Title

Status

FY'94

FY'95

FY'96

FY'97

FY'98

94-98 Total

Projected

FY'99

HHS-1

Health Assessment of Persian Gulf War Veterans from Iowa

Ongoing

 

$1,764,782

$1,616,755

$0

$0

$3,381,537

$162,000

HHS-2

Disease Cluster in a Pennsylvania Air National Guard Unit, EPI-AID 95-18

Ongoing

 

$750,000

$0

$0

$16,055

$766,055

$0

HHS-3

Biomarkers of Susceptibility and Polycyclic Aromatic Hydrocarbon (PAH) Exposure in Urine and blood Cell DNA from U.S. Army Soldiers Exposed to Kuwaiti Oil

Complete

$0

$0

$0

$0

 

$0

 

HHS-4

Suspected Increase of Birth Defects and health Problems Among Children Born to Persian Gulf War Veterans In Mississippi

Complete

$0

$0

     

$0

 

HHS-5

Cognitive Function and Symptom Patterns in Gulf War Veterans

Ongoing

       

$600,000

$600,000

$558,000

HHS-6

Defining Gulf War Illness

Ongoing

       

$600,000

$600,000

$480,000

HHS-7

Immunotoxicity of Dermal Permethrinand Cis-Urcanic Acid

Ongoing

       

$175,706

$175,706

$192,445

HHS-8

Strategy to Identify Non-Additive Response to Chemical Mixtures

Ongoing

       

$242,586

$242,586

$247,933

  HHS Total Funds  

$0

$2,514,782

$1,616,755

$0

$1,634,347

$5,765,884

$1,640,378

 

Department of Veterans Affairs Funding

Project #

Title

Status

FY'94

FY'95

FY'96

FY'97

FY'98

94-98 Total

Projected FY'99

VA-1

VA Mortality Study and VA National Health Survey of Persian Gulf Veterans (combined for FY'94-97); VA Mortality Study (FY' 98 -present)

Ongoing

$546,000

$340,000

$1,980,000

$440,032

$178,197

$3,484,229

$166,848

VA-2

VA National Survey of Persian Gulf Veterans

Ongoing

         

$0

 

VA-2A

VA National Survey of Persian Gulf Veterans - Phase I

Complete

       

$18,111

$18,111

 

VA-2B

VA National Survey of Persian Gulf Veterans - Phase II

Ongoing

       

$271,551

$271,551

$0

VA-2C

VA National Survey of Persian Gulf Veterans - Phase III

Ongoing

       

$1,601,280

$1,601,280

$2,340,774

VA-3

Use of Roster of Veterans Who Served in Persian Gulf Area

Complete

       

$0

   

VA-4

Boston Environmental Hazards Research

Ongoing

$98,300

$500,000

$500,000

$500,000

$500,000

$2,098,300

$500,000

VA-4A

Evaluation of Cognitive Functioning of PGWVs

Ongoing

         

$0

 

VA-4B

Evaluation of Neurological Functioning in Persian Gulf Veterans (see new HHS-5)

Complete

         

$0

 

VA-4C

Gulf War And Vietnam Veterans Cancer Incidence Surveillance

Ongoing

         

$0

 

VA-4COR

Boston Environmental Hazards Research Center - Core

Ongoing

         

$0

 

VA-4D

Evaluation of Respiratory Dysfunction Among Gulf War

Ongoing

         

$0

 

VA-4E

The Aromatic Hydrocarbon Receptor (AhR) as a Biomarker of Susceptibility

Ongoing

         

$0

 

VA-4F

Validity of Computerized Tests

Ongoing

         

$0

 

VA-5

East Orange Environmental Hazards Research Center

Ongoing

$100,000

$500,000

$500,000

$500,000

$500,000

$2,100,000

$500,000

VA-5A

Health and Exposure Survey of Persian Gulf Veterans

Ongoing

         

$0

 

VA-5B

Physiological and Psychological Assessments of Persian Gulf Veterans

Complete

         

$0

 

VA-5C

Effects of Exertion and Chemical Stress on Persian Gulf Veterans

Ongoing

         

$0

 

VA-5COR

East Orange Environmental Hazards Research Center - Core

Ongoing

         

$0

 

VA-5D

Effects of Genetics and Stress on Responses to Environmental Toxins

Complete

         

$0

 

VA-6

Portland Environmental Hazards Research Center: Environment, Veterans Health and the Gulf War Syndrome

Ongoing

$99,279

$499,583

$498,695

$499,198

$499,926

$2,096,681

$500,000

VA-6A

Psychosocial, Neuropsychological and Neurobehavioral Assessment (Project I)

Ongoing

         

$0

 

VA-6B

Clinical and Neuroendocrine Aspects of Fibromyalgia (Project II)

Ongoing

         

$0

 

VA-6C

Neurotoxicity of Environmental Pollutants and Warfare Agents (Project III)

Ongoing

         

$0

 

VA-6COR

Core: Portland Environmental Hazards Research Center: Environment, Veterans Health and the Gulf War Syndrome. Core Project for Clinical and Epidemiology Research

Ongoing

         

$0

 

VA-6D

DNA Damage from Chemical Agents and Its Repair (Project IV)

Ongoing

         

$0

 

VA-6E

Clinical and Epidemiology Leishmania Research

Ongoing

         

$0

 

VA-7

Desert Storm Reunion Survey

Complete

$0

$50,000

     

$50,000

 

VA-8

Psychological Test Data of Gulf War Veterans Over Time

Ongoing

$0

$0

$0

$0

$0

$0

$0

VA-9

Evaluation of Cognitive Functioning in Persian Gulf War Veterans Reporting War-related Health Problems

Complete

$0

$0

$20,000

   

$20,000

 

VA-10

Memory and Attention in PTSD

Ongoing

$0

$0

$63,700

$57,000

$57,600

$178,300

$0

VA-11

Neuropsychological Functioning in Veterans

Complete

$0

$0

     

$0

 

VA-12

Psychological Assessment of Operation Desert Storm

Complete

$0

$0

$0

$0

 

$0

 

VA-13

Neurobehavioral Aspects of Persian Gulf Experiences: A Pilot Study

Complete

$0

$50,000

     

$50,000

 

VA-15

Vaccine-Mediated Immunity Against Leishmaniasis

Ongoing

$64,300

$64,300

$0

$82,600

$80,000

$291,200

$79,400

VA-16

Protective Immunity in Experimental Visceral Leishmaniasis

Complete

 

$60,200

$60,700

$54,900

 

$175,800

 

VA-17

Immunological Evaluation of Persian

Complete

$0

$0

     

$0

 

VA-18

Chronic Gastrointestinal Illness in Persian Gulf Veterans

Complete

 

$0

$0

   

$0

 

VA-20

Psychological Adjustment in Operation Desert Shield/Storm

Complete

         

$0

 

VA-21

A Comparison of PTSD Symptomatology among Three Army Medical Units Involved in ODS

Complete

$0

$0

     

$0

 

VA-36

Stress Symptoms and Their Causal Attribution in Desert Storm Veterans

Complete

 

$0

$0

$0

 

$0

 

VA-40

Musculoskeletal Symptoms in Gulf War Syndrome

Ongoing

$0

$0

$0

$0

$0

$0

$0

VA-46

Diarrhea in Persian Gulf Veterans: An Irritable Bowel-Like Disorder

Ongoing

 

$0

$0

$0

$0

$0

$0

VA-47

Retrospective Verification of Mustard

Ongoing

     

$37,300

$37,300

$74,600

$37,300

VA-48

Cross-Sensitization as a CNS Model for Gulf War Chemical Intolerance

Ongoing

       

$99,900

$99,900

$98,800

VA-49

Sensitivity to Pyridostigmine Bromide: Persistent Neural Dysfunction

Ongoing

       

$184,400

$184,400

$13,300

VA-50

Neuropsychological Function in Gulf War Veterans

Complete

 

$0

$0

$0

 

$0

 

VA-51

Psychobiological Assessment of Desert Storm Veterans

Ongoing

$0

$0

$0

$0

$0

$0

$0

VA-53

Spouses and Children Program

Ongoing

     

$101,360

$98,651

$200,011

$1,799,989

VA-54

Follow-up of Psychological and Neurocognitive Gulf War Outcomes: Relation to Stress

Ongoing

         

$0

$102,000

VA-55

Antibiotic Treatment of Gulf War Veterans' Illnesses

Ongoing

       

$50,000

$50,000

$2,000,000

  VA Total Funds  

$907,879

$2,064,083

$3,623,095

$2,272,390

$4,176,916

$13,044,363

$8,138,411

 

VA/DoD Programs Funding

Project #

Title

Status

FY'94

FY'95

FY'96

FY'97

FY'98

94-98 Total

Projects FY'99

VA/DoD-1D

VA Cooperative Study 470: A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans with Gulf War Illnesses (GWIs)          

$4,500,000

$4,500,000

 

VA/DoD-1V

VA Cooperative Study 470: A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans with GWIs

Ongoing

       

$50,000

$50,000

$2,500,000

VA/DoD-2D

VA/DoD Core Funding of the Medical Follow-Up Agency

Ongoing

$250,000

$250,000

$250,000

$250,000

$250,000

$1,250,000

$250,000

VA/DoD-2DA

Follow-Up Investigation of Troops Exposed to Nerve Agents at Aberdeen Proving Ground (Pilot Study)            

$0

 

VA/DoD-2DB

Patterns of Pre-Persian Gulf War Illness and Health Care Seeking - Pilot Study            

$0

 

VA/DoD-2V

VA/DoD Core Funding of the Medical Follow-Up Agency

Ongoing

$250,000

$250,000

$250,000

$250,000

$250,000

$1,250,000

$250,000

VA/DoD-2VA

Follow-Up Investigation of Troops Exposed to Nerve Agents at Aberdeen Proving Ground (Pilot Study)

Complete

         

$0

 

VA/DoD-2VB

Patterns of Pre-Persian Gulf War Illness and Health Care Seeking-Pilot Study

Complete

         

$0

 
  VA/DoD Total Funds

$500,000

$500,000

$500,000

$500,000

$5,050,000

$7,050,000

$3,000,000